Inventor
Eva van Rooij
Inventor
Utrecht, NL
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes23%
A01KAnimal husbandry10%
A61LMethods or apparatus for sterilising materials or objects in general8%
Y02ATechnologies for adaptation to climate change8%
C07HSugars2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
10,392,618Micro-RNA family that modulates extracellular matrix genes and uses thereof201910,337,005Oligonucleotide-based inhibitors comprising locked nucleic acid motif20199,994,847miR-29 mimics and uses thereof20189,803,202'Oligonucleotide-based inhibitors comprising locked nucleic acid motif'20179,752,143'Locked nucleic acid inhibitor of miR-145 and uses thereof'20179,719,086'Micro-RNA family that modulates fibrosis and uses thereof'20179,719,087'Micro-RNA family that modulates fibrosis and uses thereof'20179,719,088'Micro-RNA family that modulates fibrosis and uses thereof'20179,428,749'Control of whole body energy homeostasis by microRNA regulation'20169,388,408'Oligonucleotide-based inhibitors comprising locked nucleic acid motif'20169,376,681'miR-29 mimics and uses thereof'20169,163,235'Inhibitors of the miR-15 family of micro-RNAs'20159,078,919'Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair'20159,072,765'Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure'20158,962,588'Micro-RNAS that control myosin expression and myofiber identity'20158,940,712'Micro-RNA family that modulates fibrosis and uses thereof'20158,940,713'Micro-RNA family that modulates fibrosis and uses thereof'20158,940,711'Micro-RNA family that modulates fibrosis and uses thereof'20158,642,751'MicroRNA inhibitors comprising locked nucleotides'20148,629,119'Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders'20148,513,209'Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair'20138,481,507'Micro-RNAs that control myosin expression and myofiber identity'20138,440,636'Micro-RNA family that modulates fibrosis and uses thereof'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2019Patents assigned to UNIV TEXAS (15)· patent assignee history
2013–2015Patents assigned to VAN ROOIJ EVA (6)· patent assignee history
2013–2014Patents assigned to OLSON ERIC (4)· patent assignee history
2013–2015Based in Boulder, CO, US· patent location history
2014–2015Patents assigned to MIRAGEN THERAPEUTICS (2)· patent assignee history
2015–2019Patents assigned to MIRAGEN THERAPEUTICS INC (8)· patent assignee history
2015–2019Based in Utrecht, NL· patent location history
2017–2019Based in Ultrecht, NL· patent location history
2017Based in Utretcht, NL· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 15 | 2013–2019 |
| MIRAGEN THERAPEUTICS INC | 8 | 2015–2019 |
| VAN ROOIJ EVAself | 6 | 2013–2015 |
| OLSON ERIC | 4 | 2013–2014 |
| MIRAGEN THERAPEUTICS | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Utrecht, NL | 13 | 2015–2019 |
| Boulder, CO, US | 7 | 2013–2015 |
| Ultrecht, NL | 2 | 2017–2019 |
| Utretcht, NL | 1 | 2017 |